FindTrial
Sign In

Administering aspirin and rivaroxaban to prevent deep venous thrombosis after total hip arthroplasty:a prospective randomised control trial

Administering aspirin and rivaroxaban to prevent deep venous thrombosis after total hip arthroplasty:a prospective randomised control trial

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR-INR-17013547
Enrollment
Unknown
Registered
2017-11-26
Start date
2018-01-01
Completion date
Unknown
Last updated
2017-11-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

deep vein thrombosis

Interventions

Two groups:aspirin versus rivaroxaban

Sponsors

Department of Orthopaedic Surgery, West China Hospital, West China Medical School, Sichuan University
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: patients who undergo unilateral total hip arthroplasty for osteoarthritis; patients who are willing to participate this study and sign up the informed consent form

Exclusion criteria

Exclusion criteria: patients who had a history of hemorrhagic disease or a bleeding tendency during the preoperative coagulation test, had a medical history of VTE or lower limb artherosclerosis, or used a combination of other drugs that might impact the findings

Design outcomes

Primary

MeasureTime frame
deep vein thrombosis postoperative;—

Countries

China

Contacts

Public ContactBin Shen

Department of Orthopaedic Surgery, West China Hospital, West China Medical School, Sichuan University

shenbin_1971@163.com+86 13408682290

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026